title: Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.
authors: Louisa
authors: L
authors: Kent
authors: Paul
authors: P
authors: Davies
authors: Robin
authors: R
authors: Kennett
authors: Sunil
authors: S
authors: Wimalaratna
authors: Richard
authors: R
authors: Kerr
authors: Martin R
authors: MR
authors: Turner
authors: Kevin
authors: K
authors: Talbot
mesh_terms: D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
references: J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):417-8
references: 11248905
references: J Neurol Sci. 2001 Sep 15;190(1-2):95-7
references: 11574113
references: Clin Neuropharmacol. 2010 Sep-Oct;33(5):243-7
references: 20852412
references: J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1594-6
references: 16227561
references: Am J Phys Med Rehabil. 2008 Apr;87(4):321-4
references: 18303472
references: J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1235-6
references: 8229041
references: J Neurol Neurosurg Psychiatry. 1992 Sep;55(9):844-5
references: 1328540
references: J Neural Transm (Vienna). 2010 Nov;117(11):1293-4
references: 20953643